PMID- 29721512
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20191120
IS  - 2324-7096 (Print)
IS  - 2324-7096 (Electronic)
IS  - 2324-7096 (Linking)
VI  - 5
IP  - 3
DP  - 2017 Jul-Sep
TI  - Etanercept-Induced Hypoglycemia in a Patient With Psoriatic Arthritis and 
      Diabetes.
PG  - 2324709617727760
LID - 10.1177/2324709617727760 [doi]
LID - 2324709617727760
AB  - Psoriatic arthritis (PsA) is an inflammatory arthritis associated with psoriasis 
      and inflammation involving the axial skeleton and/or peripheral joints. It is 
      more likely to be associated with metabolic syndrome and diabetes when compared 
      with other inflammatory arthritides. Tumor necrosis factor-alpha (TNF-alpha) is one of 
      several cytokines often elevated in rheumatologic disorders including PsA and has 
      also been found to be elevated in patients with obesity, metabolic syndrome, 
      diabetes, and/or atherosclerotic disease. We describe the case of a patient with 
      PsA as well as poorly controlled type 2 diabetes mellitus who experienced not 
      only improvement in his psoriasis and arthritis with the anti-TNF-alpha agent 
      etanercept but also recurrent hypoglycemia and significant improvement in 
      hemoglobin A1c despite discontinuation of all conventional therapy for diabetes.
FAU - Pfeifer, Emily C
AU  - Pfeifer EC
AD  - University of Colorado, Anschutz Medical Campus, Aurora, CO, USA.
FAU - Saxon, David R
AU  - Saxon DR
AD  - University of Colorado, Anschutz Medical Campus, Aurora, CO, USA.
AD  - Denver Veterans Affairs Medical Center, Denver, CO, USA.
FAU - Janson, Robert W
AU  - Janson RW
AD  - University of Colorado, Anschutz Medical Campus, Aurora, CO, USA.
AD  - Denver Veterans Affairs Medical Center, Denver, CO, USA.
LA  - eng
PT  - Journal Article
DEP - 20170908
PL  - United States
TA  - J Investig Med High Impact Case Rep
JT  - Journal of investigative medicine high impact case reports
JID - 101624758
PMC - PMC5917447
OTO - NOTNLM
OT  - diabetes mellitus
OT  - etanercept
OT  - hypoglycemia
OT  - psoriatic arthritis
COIS- Declaration of Conflicting Interests: The author(s) declared no potential 
      conflicts of interest with respect to the research, authorship, and/or 
      publication of this article.
EDAT- 2018/05/04 06:00
MHDA- 2018/05/04 06:01
PMCR- 2017/09/08
CRDT- 2018/05/04 06:00
PHST- 2017/06/15 00:00 [received]
PHST- 2017/07/20 00:00 [revised]
PHST- 2017/07/29 00:00 [accepted]
PHST- 2018/05/04 06:00 [entrez]
PHST- 2018/05/04 06:00 [pubmed]
PHST- 2018/05/04 06:01 [medline]
PHST- 2017/09/08 00:00 [pmc-release]
AID - 10.1177_2324709617727760 [pii]
AID - 10.1177/2324709617727760 [doi]
PST - epublish
SO  - J Investig Med High Impact Case Rep. 2017 Sep 8;5(3):2324709617727760. doi: 
      10.1177/2324709617727760. eCollection 2017 Jul-Sep.